✦ LIBER ✦

Lymphoma despite metabolic reconstitution in adenosine deaminase deficiency-severe combined immunodeficiency

✍ Scribed by Sarah S. Long

Book ID: 113744168
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 82 KB
Volume: 151
Category: Article
ISSN: 1097-6833
DOI: 10.1016/j.jpeds.2007.05.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adenosine deaminase deficiency and sever

Adenosine deaminase deficiency and severe combined immunodeficiencies

✍ Rodney E. Kellems; Cho-Yau Yeung; Diane E. Ingolia 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 666 KB

Adenosine deaminase deficiency and sever

Adenosine deaminase deficiency and severe combined immunodeficiency disease

✍ Martin B. Van der Weyden; William N. Kelley 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Burkitt’s Lymphoma in a Patient with Ade

Burkitt’s Lymphoma in a Patient with Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency Treated with Polyethylene Glycol-Adenosine Deaminase

✍ Maitham Husain; Eyal Grunebaum; Ahmed Naqvi; Adelle Atkinson; Bo-Yee Ngan; Aless 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Gene therapy for adenosine-deaminase-def

Gene therapy for adenosine-deaminase-deficient severe combined immunodeficiency

✍ Alessandro Aiuti 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 121 KB

A family of adenosine deaminase deficien

A family of adenosine deaminase deficiency with severe combined immunodeficiency

✍ Shigeru Tsuchiya; Kuniaki Narisawa; Tasuke Konno; Keiya Tada 📂 Article 📅 1979 🏛 Nature Publishing Group 🌐 English ⚖ 187 KB

Severe combined immunodeficiency disease

Severe combined immunodeficiency disease, adenosine deaminase deficiency and gene therapy

✍ Robertson Parkman; Erwin W Gelfand 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 741 KB

Patients with severe combined immunodeficiency disease represent a model for the first clinical applications of gene therapy. Present attempts use insertion of the human adenosine deaminase gene into the peripheral blood T lymphocytes of patients who lack this gene. The ultimate treatment, however,